122 related articles for article (PubMed ID: 21568213)
41. Accurate quantitation for in vitro refolding of single domain antibody fragments expressed as inclusion bodies by referring the concomitant expression of a soluble form in the periplasms of Escherichia coli.
Noguchi T; Nishida Y; Takizawa K; Cui Y; Tsutsumi K; Hamada T; Nishi Y
J Immunol Methods; 2017 Mar; 442():1-11. PubMed ID: 27939301
[TBL] [Abstract][Full Text] [Related]
42. Microfluidic chips with multi-junctions: an advanced tool in recovering proteins from inclusion bodies.
Yamaguchi H; Miyazaki M
Bioengineered; 2015; 6(1):1-4. PubMed ID: 25531187
[TBL] [Abstract][Full Text] [Related]
43. High-yield expression of human vascular endothelial growth factor VEGF(165) in Escherichia coli and purification for therapeutic applications.
Pizarro SA; Gunson J; Field MJ; Dinges R; Khoo S; Dalal M; Lee M; Kaleas KA; Moiseff K; Garnick S; Reilly DE; Laird MW; Schmelzer CH
Protein Expr Purif; 2010 Aug; 72(2):184-93. PubMed ID: 20302942
[TBL] [Abstract][Full Text] [Related]
44. Recombinant human epidermal growth factor inclusion body solubilization and refolding at large scale using expanded-bed adsorption chromatography from Escherichia coli.
Sharma K; Babu PV; Sasidhar P; Srinivas VK; Mohan VK; Krishna E
Protein Expr Purif; 2008 Jul; 60(1):7-14. PubMed ID: 18430585
[TBL] [Abstract][Full Text] [Related]
45. Expression, purification, and refolding of a recombinant human bone morphogenetic protein 2 in vitro.
Zhang Y; Ma Y; Yang M; Min S; Yao J; Zhu L
Protein Expr Purif; 2011 Feb; 75(2):155-60. PubMed ID: 20691269
[TBL] [Abstract][Full Text] [Related]
46. Optimization of conditions for high-level expression and purification of human recombinant consensus interferon (rh-cIFN) and its characterization.
Ahmed N; Bashir H; Zafar AU; Khan MA; Tahir S; Khan F; Khan MI; Akram M; Husnain T
Biotechnol Appl Biochem; 2015; 62(5):699-708. PubMed ID: 25402716
[TBL] [Abstract][Full Text] [Related]
47. Aggregation of ALS mutant superoxide dismutase expressed in Escherichia coli.
Leinweber B; Barofsky E; Barofsky DF; Ermilov V; Nylin K; Beckman JS
Free Radic Biol Med; 2004 Apr; 36(7):911-8. PubMed ID: 15019975
[TBL] [Abstract][Full Text] [Related]
48. Refolding, purification, and activation of miniplasminogen and microplasminogen isolated from E. coli inclusion bodies.
Medynski D; Tuan M; Liu W; Wu S; Lin X
Protein Expr Purif; 2007 Apr; 52(2):395-402. PubMed ID: 17126563
[TBL] [Abstract][Full Text] [Related]
49. Expression, refolding and purification of a human interleukin-17A variant.
Wu B; Nemeth JF; Janecki DJ; Jones B; Obmolova G; Malia TJ; Baker A; Bethea D; Elloso MM; Naso M; Taudte S
Cytokine; 2011 Jan; 53(1):107-14. PubMed ID: 20674388
[TBL] [Abstract][Full Text] [Related]
50. Comparison of the purification of biologically active IL-7 cytokine expressed in Escherichia coli and Pichia pastoris.
Zaremba-Czogalla M; Stumpp C; Bonifacio E; Paul R
Protein Expr Purif; 2015 Jun; 110():65-71. PubMed ID: 25703052
[TBL] [Abstract][Full Text] [Related]
51. Chromatographic methods for the isolation of, and refolding of proteins from, Escherichia coli inclusion bodies.
Gu Z; Weidenhaupt M; Ivanova N; Pavlov M; Xu B; Su ZG; Janson JC
Protein Expr Purif; 2002 Jun; 25(1):174-9. PubMed ID: 12071713
[TBL] [Abstract][Full Text] [Related]
52. [Prokaryotic expression, purification, refolding and biological assays of recombinant human interleukin 4 inclusion body].
Li J; Cui K; Wen J; Zhao Z; Chen P; Tian L; Kan B; Wen Y; Deng H; Fan L; Wei Y
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Aug; 24(4):866-9. PubMed ID: 17899762
[TBL] [Abstract][Full Text] [Related]
53. Protein recovery from inclusion bodies of Escherichia coli using mild solubilization process.
Singh A; Upadhyay V; Upadhyay AK; Singh SM; Panda AK
Microb Cell Fact; 2015 Mar; 14():41. PubMed ID: 25889252
[TBL] [Abstract][Full Text] [Related]
54. L-cysteine-enhanced renaturation of bioactive soluble tumor necrosis factor ligand family member LIGHT from inclusion bodies in Escherichia coli.
Tsuji I; Mastui H; Ito T; Kurokawa T; Shintani Y
Protein Expr Purif; 2011 Dec; 80(2):239-45. PubMed ID: 21745574
[TBL] [Abstract][Full Text] [Related]
55. Production and purification of refolded recombinant Plasmodium falciparum beta-ketoacyl-ACP reductase from inclusion bodies.
Karmodiya K; Srivastav RK; Surolia N
Protein Expr Purif; 2005 Jul; 42(1):131-6. PubMed ID: 15939298
[TBL] [Abstract][Full Text] [Related]
56. Refolding, purification, and characterization of constitutive-active human-Smad8 produced as inclusion bodies in ClearColi® BL21 (DE3).
Segovia-Trinidad CL; Quaas B; Li Z; Lavrentieva A; Roger Y; Scheper T; Hoffmann A; Rinas U
Protein Expr Purif; 2021 Aug; 184():105878. PubMed ID: 33812004
[TBL] [Abstract][Full Text] [Related]
57. [Fast separation and preparation of proteomics samples of human serum using high performance hydrophobic interaction chromatographic cake].
Li Y; Bai Q; Chen G; Wang L
Se Pu; 2008 May; 26(3):331-4. PubMed ID: 18724670
[TBL] [Abstract][Full Text] [Related]
58. High throughput purification of recombinant human growth hormone using radial flow chromatography.
Singh SM; Sharma A; Panda AK
Protein Expr Purif; 2009 Nov; 68(1):54-9. PubMed ID: 19500673
[TBL] [Abstract][Full Text] [Related]
59. Expression, purification, and refolding of biologically active Acinetobacter baumannii OmpA from Escherichia coli inclusion bodies.
McConnell MJ; Pachón J
Protein Expr Purif; 2011 May; 77(1):98-103. PubMed ID: 21130880
[TBL] [Abstract][Full Text] [Related]
60. Expression, purification, and in vitro refolding of soluble tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
Lin Z; Lei H; Cao P
Protein Expr Purif; 2007 Feb; 51(2):276-82. PubMed ID: 17079165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
